Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease.
Schmidt, Carsten
Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease. [electronic resource] - Pathobiology : journal of immunopathology, molecular and cellular biology - 177-83 p. digital
Publication Type: Journal Article; Review
1015-2008
10.1159/000068151 doi
Animals
Antibodies, Blocking--therapeutic use
Colitis, Ulcerative--immunology
Crohn Disease--immunology
Dimerization
Disease Models, Animal
Humans
Immunotherapy
Immunotoxins--therapeutic use
Interleukin-12--antagonists & inhibitors
Interleukin-12 Subunit p40
Macrophage-1 Antigen--immunology
Mice
Protein Subunits--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Th1 Cells--drug effects
Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease. [electronic resource] - Pathobiology : journal of immunopathology, molecular and cellular biology - 177-83 p. digital
Publication Type: Journal Article; Review
1015-2008
10.1159/000068151 doi
Animals
Antibodies, Blocking--therapeutic use
Colitis, Ulcerative--immunology
Crohn Disease--immunology
Dimerization
Disease Models, Animal
Humans
Immunotherapy
Immunotoxins--therapeutic use
Interleukin-12--antagonists & inhibitors
Interleukin-12 Subunit p40
Macrophage-1 Antigen--immunology
Mice
Protein Subunits--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Th1 Cells--drug effects